scholarly article | Q13442814 |
P50 | author | Herbert L. DuPont | Q29563314 |
P2093 | author name string | Robert Steffen | |
David E Greenberg | |||
Zhi-Dong Jiang | |||
Mangala P Verenker | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
inflammation | Q101991 | ||
diarrhea | Q40878 | ||
Enteroaggregative Escherichia coli | Q1344595 | ||
P304 | page(s) | 944-949 | |
P577 | publication date | 2002-03-19 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity | |
P478 | volume | 185 |
Q36394728 | A new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen |
Q39046503 | A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital |
Q37651476 | Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity |
Q37097646 | Animal models of enteroaggregative Escherichia coli infection |
Q30432798 | Association between TNF-alpha and Entamoeba histolytica diarrhea |
Q35690358 | Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries |
Q33675794 | Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections |
Q37191241 | Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli |
Q36505498 | Current and future developments in travelers' diarrhea therapy |
Q30443288 | Enteric infections, diarrhea, and their impact on function and development |
Q40532416 | Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation |
Q38024836 | Enteroaggregative Escherichia coli pathotype: a genetically heterogeneous emerging foodborne enteropathogen |
Q21328680 | Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen |
Q54509537 | Enteroaggregative Escherichia coli: An Emerging Pathogen. |
Q35716649 | Enteroaggregative Escherichia coli: an emerging enteric pathogen |
Q33689258 | Enteroaggregative coli: A Pathogen Bridging the North and South |
Q45071462 | Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut. |
Q36396783 | Enterotoxigenic Escherichia coli prevents host NF-κB activation by targeting IκBα polyubiquitination |
Q34057621 | Epidemiology and clinical manifestations of enteroaggregative Escherichia coli |
Q40109314 | Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort |
Q40302349 | Epithelial cells secrete interleukin-8 in response to adhesion and invasion of diffusely adhering Escherichia coli lacking Afa/Dr genes |
Q34294931 | Escherichia coli expressing EAST1 toxin did not cause an increase of cAMP or cGMP levels in cells, and no diarrhea in 5-day old gnotobiotic pigs |
Q35067103 | Fecal leukocytes in children infected with diarrheagenic Escherichia coli |
Q41106623 | Human norovirus infection and the acute serum cytokine response. |
Q94521258 | Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease |
Q36575325 | Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. |
Q39537395 | In Silico and In Vitro Studies of Truncated Forms of Flagellin (FliC) of Enteroaggregative Escherichia coli (EAEC). |
Q34251481 | Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies |
Q33712186 | Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli |
Q39255777 | Is the interleukin 8 promoter polymorphism rs4073/-251T >A associated with Clostridium difficile infection? |
Q37964040 | Lactoferrin, a key molecule in immune and inflammatory processes |
Q96816103 | Mucus layer modeling of human colonoids during infection with enteroaggragative E. coli |
Q30430377 | Pediatric diarrhea in Southern Ghana: Etiology and association with intestinal inflammation and malnutrition |
Q53285940 | Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. |
Q47122481 | Prediction model and treatment of high-output ileostomy in colorectal cancer surgery |
Q34974972 | Prevention and self-treatment of traveler's diarrhea |
Q41837851 | Proinflammatory fecal mRNA and childhood bacterial enteric infections |
Q39695148 | Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers |
Q34595945 | Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fluid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells |
Q64067847 | TLR4 Participates in the Inflammatory Response Induced by the AAF/II Fimbriae From Enteroaggregative Escherichia coli on Intestinal Epithelial Cells |
Q40046016 | Travelers' diarrhea: an update on susceptibility, prevention, and treatment |
Q46901378 | Travelers' diarrhea: modern concepts and new developments |
Q33235907 | Travellers' diarrhoea: contemporary approaches to therapy and prevention |
Q34585296 | Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections |
Search more.